Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

BioNexus Gene Lab (BGLC) Receivables - Net (2020 - 2025)

BioNexus Gene Lab's Receivables - Net history spans 6 years, with the latest figure at $1.2 million for Q4 2025.

  • Quarterly results put Receivables - Net at $1.2 million for Q4 2025, down 12.11% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (down 12.11% YoY), and the annual figure for FY2025 was $1.2 million, down 12.11%.
  • Receivables - Net for Q4 2025 was $1.2 million at BioNexus Gene Lab, down from $1.5 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $4.2 million in Q3 2021 to a low of $799674.0 in Q4 2023.
  • The 5-year median for Receivables - Net is $2.0 million (2023), against an average of $2.2 million.
  • The sharpest move saw Receivables - Net tumbled 72.12% in 2023, then skyrocketed 87.47% in 2025.
  • Year by year, Receivables - Net stood at $3.4 million in 2021, then fell by 14.55% to $2.9 million in 2022, then tumbled by 72.12% to $799674.0 in 2023, then surged by 72.14% to $1.4 million in 2024, then dropped by 12.11% to $1.2 million in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $1.2 million, $1.5 million, and $1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.